Protagenic Therapeutics, Inc.\new PTIX
OTC PTIX
$0.75 -0.01 (-1.32%)
At close: Oct 20, 2026 · 4:00 PM EDT

Protagenic Therapeutics, Inc.\new (PTIX) Capital Expenditures (2013 - 2023)

Updated

Protagenic Therapeutics, Inc.\new (PTIX) posted Capital Expenditures of $3,297 for FY2026 (year ended Mar 31, 2026).

Analysis

Protagenic Therapeutics, Inc.\new (PTIX) Capital Expenditures (2013 - 2023) Analysis & Trends

Since FY2014, Protagenic Therapeutics, Inc.\new has reported Capital Expenditures for 5 fiscal years.

  • Annual Capital Expenditures shows a four-year compound annual growth rate of 16.3% (FY2022 to FY2026).
  • The FY2026 figure stands as the highest annual Capital Expenditures since FY2023.
  • Business Quant data shows PTIX's Capital Expenditures at $149,775 in FY2023 and $1,805 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 322.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 140.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 533.00 Mn
10 Protagenic Therapeutics, Inc.\new 1.36 Mn 1.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 93,969.00
Dec 31, 2015 791.00
Mar 31, 2015 1,000.00
Sep 30, 2013 1,000.00
API Access

Protagenic Therapeutics, Inc.\new Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PTIX&period=max&api_key=YOUR_API_KEY